Join
Live feed
·
INSIDERFilingvia Quantisnow
Arcutis Biotherapeutics Inc. logo

SVP Chief Financial Officer Vairavan Latha sold $9,157 worth of shares (435 units at $21.05), decreasing direct ownership by 0.50% to 85,978 units (SEC Form 4) to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
ARQT· Arcutis Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARQT (Arcutis Biotherapeutics Inc.) and more on Quantisnow.

SVP Chief Financial Officer Vairavan Latha sold $9,157 worth of shares (435 units at $21.05), decreasing direct ownership by 0.50% to 85,978 units (SEC Form 4) to cover withholding tax | Quantisnow